41 – 50 of 396
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Role of cgrp in migraine
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Rimegepant oral disintegrating tablet for migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article
-
Mark
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
(
- Contribution to journal › Scientific review
-
Mark
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
(
- Contribution to journal › Article
-
Mark
Dr James Lance, Professor of Neurology in Sydney, Australia, died on 20 February 2019, age 92
(
- Contribution to journal › Article
-
Mark
The changing faces of migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
(
- Contribution to journal › Article
-
Mark
Discovery of CGRP in relation to migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Distribution of CGRP and CGRP receptor components in the rat brain
(
- Contribution to journal › Article